Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
2015 · Journal of Clinical Oncology · 312 citations
https://doi.org/10.1200/jco.2014.58.3401
M
Melinda S. Yates
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
157
Papers
4.0K
Citations
30
h-index
41
i10-index
Melinda S. Yates is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Endometrial and Cervical Cancer Treatments & Genetic factors in colorectal cancer & Ovarian cancer diagnosis and treatment. The author has an h-index of 30, co-authored 134 publications.
ORCID: 0000-0001-9450-5517Papers by this author
worksAndrogen receptor blockade promotes response to BRAF/MEK-targeted therapy
2022 · Nature · 129 citations
https://doi.org/10.1038/s41586-022-04833-8
Intervening on impostor phenomenon: prospective evaluation of a workshop for health science students using a mixed-method design
2022 · BMC Medical Education · 20 citations
https://doi.org/10.1186/s12909-022-03824-7
Mitochondrial defects and metabolic vulnerabilities in Lynch syndrome–associated MSH2-deficient endometrial cancer
2025 · JCI Insight · 6 citations
https://doi.org/10.1172/jci.insight.185946
Uterine-Conserving Treatment Options for Atypical Endometrial Hyperplasia and Early Endometrial Cancer
2024 · Current Oncology Reports · 1 citations
https://doi.org/10.1007/s11912-024-01603-9
Supplementary Table S4 from Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion
2024 · 0 citations
https://doi.org/10.1158/1078-0432.27754801
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat